Recommended for its ‘creative thinking’, Taylor Wessing LLP is highly adept at handling big-ticket litigation for a litany of patents, and is notably active in the Patents Court in relation to complex healthcare and pharmaceutical issues. Multi-jurisdictional litigator Nigel Stoate leads the practice with his wealth of experience that spans the medical devices, pharmaceutical, telecoms, chemical, and engineering industries. Matthew Royle leverages his background in molecular immunology to assist players in the pharmaceutical, biotech, and life sciences industries, whereas Mike Washbrook acts in high-calibre technology mandates. Andrew Payne is another key name to note.
L’éditorial du Legal 500
- Profil
- Réseaux sociaux
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
'They possess creative thinking and dare to challenge the status quo of the law.'
'They are easy to communicate with.'
‘Taylor Wessing regularly coordinates big patent litigation projects on an outstanding level, especially for the life sciences sector.'
'The reputation of the team is high and they are a clear reference when it comes to generic work.’
'They are top-notch patent litigators and a clear choice when it comes to complex matters.'
'Andrew Payne is excellent.'
Clients clés
- Pfizer Inc
- Abbott
- Ericsson
- Shenzhen Senior Technology Materials Ltd
- OPPO
- Glenmark Pharmaceuticals Europe Limited
- Viatris
- Siemens Healthineers AG
- Energize Games
- Essential Pharma
Avocats
Les grands avocats de demain
Jeunes associés disposant d’une reconnaissance montante sur le marché, jouant régulièrement un rôle clé dans des dossiers majeurs.
Responsable de la pratique
Nigel Stoate
Autres avocats clés
Matthew Royle; Mike Washbrook; Andrew Payne